Summit Healthcare Acquisition Corp.
Status: Closed Deal
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $200.00M |
|---|---|
| IPO Date | Jun 9, 2021 |
| CEO | Bo Tan |
| Left Lead | BofA Securities |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Asia |
| Target Company | YS Biopharma |
| Deal Announced | Sep 29, 2022 |
| Deal Size, $M | $849.00M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Mar 14, 2023 |
| Amendment Vote | TBD |
| Closing Date | Mar 16, 2023 |
Formerly SMIH
LSB
LSBPW
| Price | $1.26 $0.13 |
|---|---|
| Last closing price | $1.24 |
| H/L, today | $1.18 / $1.22 |
| Volume, today | 16,101 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.